| Net loss | -7.22M |
| Depreciation expense | 596K |
| Change to allowance for doubtful accounts | |
| Unrealized gain on marketable securities | |
| (Gain) Loss on disposal of fixed assets | |
| Stock-based compensation | 943K |
| Accounts receivable | 3.92M |
| Inventories | -692K |
| Prepaid expenses and other assets | 202K |
| Accounts payable | -1.13M |
| Accrued expenses | -741K |
| Deferred revenue | 1.01M |
| Long-term liabilities | -225K |
| Net cash provided by (used in) operating activities | -3.37M |
| Purchases of property and equipment | -115K |
| Net cash used in investing activities | -115K |
| Proceeds from private placement of common stock | |
| Issuance costs of private placement | |
| Proceeds from draw on revolving line of credit | |
| Proceeds from employee stock purchases | |
| Purchases of treasury stock | |
| Net cash provided by financing activities | -1K |
| Translation gain (loss) on subsidiaries in foreign currencies | -146K |
| Change in cash and cash equivalents | -3.63M |
| Cash and cash equivalents, beginning of period | 12.26M |
| Cash and cash equivalents, end of period | 8.63M |